The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells
Stefania Fiorcari, Wells S. Brown, Bradley W. McIntyre, Zeev Estrov, Rossana Maffei, Susan O'Brien, Mariela Sivina, Julia Hoellenriegel, William G. Wierda, Michael J. Keating, Wei Ding, Neil E. Kay, Brian J. Lannutti, Roberto Marasca, Jan A. Burger
Dive into the research topics of 'The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells'. Together they form a unique fingerprint.